Cargando…
Guanidinoacetic Acid as a Nutritional Adjuvant to Multiple Sclerosis Therapy
Tackling impaired bioenergetics in multiple sclerosis (MS) has been recently recognized as an innovative approach with therapeutic potential. Guanidinoacetic acid (GAA) is an experimental nutrient that plays a significant role in high-energy phosphate metabolism. The preliminary trials suggest benef...
Autor principal: | Ostojic, Sergej M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134824/ https://www.ncbi.nlm.nih.gov/pubmed/35634212 http://dx.doi.org/10.3389/fnhum.2022.871535 |
Ejemplares similares
-
Guanidinoacetic acid in human nutrition: Beyond creatine synthesis
por: Ostojic, Sergej M., et al.
Publicado: (2023) -
Cataloguing guanidinoacetic acid content in nutritional supplements
por: Ostojic, Sergej M., et al.
Publicado: (2022) -
Guanidinoacetate–creatine in secondary progressive multiple sclerosis: a case report
por: Ostojic, Sergej M., et al.
Publicado: (2022) -
Safety of Dietary Guanidinoacetic Acid: A Villain of a Good Guy?
por: Ostojic, Sergej M.
Publicado: (2021) -
Guanidinoacetic acid deficiency: a new entity in clinical medicine?
por: Ostojic, Sergej M., et al.
Publicado: (2020)